These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17978312)

  • 1. Aberrantly glycosylated IgA1 in glomerular immune deposits of IgA nephropathy.
    Giannakakis K; Feriozzi S; Perez M; Faraggiana T; Muda AO
    J Am Soc Nephrol; 2007 Dec; 18(12):3139-46. PubMed ID: 17978312
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
    Oortwijn BD; Roos A; Royle L; van Gijlswijk-Janssen DJ; Faber-Krol MC; Eijgenraam JW; Dwek RA; Daha MR; Rudd PM; van Kooten C
    J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J; Smith AC; Feehally J
    Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical characterization of glomerular IgA deposits in IgA nephropathy.
    Suzuki S; Kobayashi H; Sato H; Arakawa M
    Clin Nephrol; 1990 Feb; 33(2):66-71. PubMed ID: 2107051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [IgA1 aberrant glycosylation in the pathogenesis of IgA nephropathy: an overivew].
    Xie L; Wang L; Huang J; Fan J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb; 27(1):227-30. PubMed ID: 20337060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mesangial proliferative glomerulonephritis].
    Yamada A
    Nihon Rinsho; 2004 Oct; 62(10):1842-6. PubMed ID: 15500128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgA nephropathy and aberrant glycosylation of tonsillar, serum and glomerular IgA1.
    Hiki Y; Ito A; Yamamoto Y; Yamamoto K; Iwase H
    Adv Otorhinolaryngol; 2011; 72():68-70. PubMed ID: 21865693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin.
    Linossier MT; Palle S; Berthoux F
    Am J Kidney Dis; 2003 Mar; 41(3):558-64. PubMed ID: 12612978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.
    Novak J; Barratt J; Julian BA; Renfrow MB
    Semin Nephrol; 2018 Sep; 38(5):461-476. PubMed ID: 30177018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.
    Hiki Y; Odani H; Takahashi M; Yasuda Y; Nishimoto A; Iwase H; Shinzato T; Kobayashi Y; Maeda K
    Kidney Int; 2001 Mar; 59(3):1077-85. PubMed ID: 11231363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunoglobulin A (IgA) and its cellular receptors: Recent advances and new pathogenetical hypothesis].
    Amore A; Monteiro R; Coppo R
    G Ital Nefrol; 2006; 23(3):313-22. PubMed ID: 16868911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylation profile of differently charged IgA1 and their binding characteristics to cultured mesangial cells in IgA nephropathy.
    Leung JC; Chan LY; Tang SC; Tam PC; Fenn J; Lai KN
    Nephron Exp Nephrol; 2007; 107(3):e107-18. PubMed ID: 17957128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histology and immunohistology of IgA nephropathy.
    Haas M
    J Nephrol; 2005; 18(6):676-80. PubMed ID: 16358224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant glycosylation in IgA nephropathy (IgAN).
    Coppo R; Amore A
    Kidney Int; 2004 May; 65(5):1544-7. PubMed ID: 15086888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodological approaches to the analysis of IgA1 O-glycosylation in IgA nephropathy.
    Allen AC
    J Nephrol; 1999; 12(2):76-84. PubMed ID: 10378662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-glycosylation of serum IgD in IgA nephropathy.
    Smith AC; de Wolff JF; Molyneux K; Feehally J; Barratt J
    J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the spectrum of immunoglobulin A-dominant/codominant glomerular deposition in diabetic nephropathy.
    Cossey LN; Messias N; Messias E; Walker PD; Silva FG
    Hum Pathol; 2014 Nov; 45(11):2294-301. PubMed ID: 25239033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
    Moura IC; Arcos-Fajardo M; Gdoura A; Leroy V; Sadaka C; Mahlaoui N; Lepelletier Y; Vrtovsnik F; Haddad E; Benhamou M; Monteiro RC
    J Am Soc Nephrol; 2005 Sep; 16(9):2667-76. PubMed ID: 15987753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in the pathogenesis of IgA nephropathy.
    Julian BA; Tomana M; Novak J; Mestecky J
    Adv Nephrol Necker Hosp; 1999; 29():53-72. PubMed ID: 10561737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding capacity of in vitro deglycosylated IgA1 to human mesangial cells.
    Zhang JJ; Xu LX; Zhang Y; Zhao MH
    Clin Immunol; 2006 Apr; 119(1):103-9. PubMed ID: 16442846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.